Zentalis Pharmaceuticals (the “Company” or “Zentalis”), a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental pathways in cancer, today announced the appointment of Melissa Epperly as Chief Financial Officer (CFO).
December 16, 2019
· 2 min read